Lotus Pharmaceutical Co., Ltd. (TPE:1795)
194.00
+2.50 (1.31%)
Aug 22, 2025, 2:38 PM CST
Lotus Pharmaceutical Revenue
Lotus Pharmaceutical had revenue of 4.75B TWD in the quarter ending June 30, 2025, with 0.09% growth. This brings the company's revenue in the last twelve months to 19.12B, up 12.91% year-over-year. In the year 2024, Lotus Pharmaceutical had annual revenue of 18.58B with 9.59% growth.
Revenue (ttm)
19.12B
Revenue Growth
+12.91%
P/S Ratio
2.67
Revenue / Employee
17.40M
Employees
1,099
Market Cap
51.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
Dec 31, 2020 | 10.73B | 1.12B | 11.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Lumosa Therapeutics | 37.25M |
Center Laboratories | 1.60B |
Pegavision | 6.67B |